Cyxone Financial Statements From 2010 to 2024
| CYXO Stock | SEK 0.03 0.01 21.57% |
Check Cyxone AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cyxone AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Cyxone financial statements analysis is a perfect complement when working with Cyxone AB Valuation or Volatility modules.
Cyxone |
Cyxone AB Company Shares Outstanding Analysis
Cyxone AB's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Cyxone AB Shares Outstanding | 98.44 M |
Most of Cyxone AB's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cyxone AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Cyxone AB has 98.44 M of shares currently outstending. This is 45.47% lower than that of the Healthcare sector and 7.87% lower than that of the Biotechnology industry. The shares outstanding for all Sweden stocks is 82.78% higher than that of the company.
Cyxone AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cyxone AB's current stock value. Our valuation model uses many indicators to compare Cyxone AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cyxone AB competition to find correlations between indicators driving Cyxone AB's intrinsic value. More Info.Cyxone AB is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cyxone AB's earnings, one of the primary drivers of an investment's value.About Cyxone AB Financial Statements
Cyxone AB shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Cyxone AB investors may analyze each financial statement separately, they are all interrelated. The changes in Cyxone AB's assets and liabilities, for example, are also reflected in the revenues and expenses on on Cyxone AB's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Cyxone AB , a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis and multiple sclerosis and treatments for virally induced acute respiratory disorders. The company was founded in 2015 and is headquartered in Malm, Sweden. Cyxone AB is traded on Stockholm Stock Exchange in Sweden.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cyxone Stock Analysis
When running Cyxone AB's price analysis, check to measure Cyxone AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyxone AB is operating at the current time. Most of Cyxone AB's value examination focuses on studying past and present price action to predict the probability of Cyxone AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyxone AB's price. Additionally, you may evaluate how the addition of Cyxone AB to your portfolios can decrease your overall portfolio volatility.